This is new hope in the fight against breast cancer (the deadliest in women). In the United Kingdom, a terminally ill patient recovered from the disease thanks to an experimental treatment.
As the saying goes, as long as there is life there is hope, and this healing is proof of that. In November 2017, Jasmin David, 51 years old and mother of two, was diagnosed with severe form of breast cancer† A few months later, a second blow fell: his disease had spread to the lungs, to the rib cage and to the lymph nodes. His vital prognosis is then engaged and the doctors give him only one year to live.
Jasmin David continues chemotherapy and radiotherapy sessions and undergoes a mastectomy that will allow her to limit the spread of her disease. Finally, the hunter decides to do a test as a last resort experimental treatment for two years† This is a Phase 1 clinical trial being conducted at the National Institute for Health and Care Research (NIHR) Clinical Research Facility (CRF) at Christie’s Hospital in Manchester.
What does this treatment consist of? According to the media the independent, it is an experimental oral drug combined with an injection every three weeks of atezolizumab, an immunotherapy drug. And against all odds, in June 2021, scanners follow, Jasmin David learns that her cancer is completely gone†
“Two and a half years ago I thought it was the end, she remembers. Now I feel like I’ve been reborn.†
Jasmine David at the independent
Christie Hospital is known as one of the largest cancer treatment centers in Europe. The doctors who practice there are constantly testing new drugs and new therapies on patients with various diseases. Objective ? Give hope back to these terminally ill people.
Today his body shows no trace of cancer. However, the Briton must continue to receive treatment until December 2023 to prevent a recurrence.